tryptophanamide

used as inhibitor of chymotrypsin; RN given refers to cpd with unspecified isomeric designation

Also Known As:

tryptophanamide monohydrochloride, (S)-isomer; tryptophanamide, (+-)-isomer; tryptophanamide, (S)-isomer; alpha-amino-1H-indole-3-propanamide

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Prostatic Neoplasms (Prostate Cancer) 01/01/2019 - "2-(N-acetyl-D-tyrosyl-trans-4-hydroxy-L-prolyl-L-asparaginyl-L-threonyl-L-phenylalanyl) hydrazinocarbonyl-L-leucyl-Nω-methyl-L-arginyl-L-tryptophanamide monoacetate (TAK-448, RVT-602), a kisspeptin analog, has been developed as a therapeutic agent for prostate cancer. "
2.	Necrosis 01/01/2021 - "L-tryptophanamide affected the proliferation, apoptosis and necrosis in HRPECs, and promoted the tube formation and migration in primary human retinal endothelial cells (HRECs). "